Injectable Steroids

Trenbolone Hexahydrobenzylcarbonate 100 mg Astera Labs

Astera Labs

90,00

In Stock (100 available)

Trenbolone Hexahydrobenzylcarbonate 100 mg Astera Labs (100 mg) — The short-acting acetate ester of Trenbolone provides rapid onset of its legendary effects — typically noticeable within days of…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Trenbolone Hexahydrobenzylcarbonate 100 mg Astera Labs — trenbolone acetate from Astera Labs at 100 mg. The short-ester trenbolone: 2-day half-life, very rapid onset, quick dose-titration if side-effects appear. EOD injections maintain stable blood levels. Always with testosterone base.

Key Benefits

  • Trenbolone — potent AR agonist, no aromatisation, progestagenic
  • Nutrient-partitioning benefit on any ester form
  • Dose and injection frequency depend on specific ester
  • Side-effect burden same across esters — not softer in any form
  • Cabergoline for prolactin, bloodwork mid-cycle mandatory
  • Each unit dosed at 100 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing depends on ester: acetate 50–100 mg EOD; enanthate 200–400 mg/week split; hex 100–200 mg/week. Cycle length 8–14 weeks by ester.

How It Works

19-nor derivative. Extreme AR affinity (~5× testosterone). Does not aromatise. Progestagenic. Potent nutrient-partitioner.

Pharmacokinetics

Ester-dependent: acetate ~1 day half-life; enanthate ~7 days; hexahydrobenzylcarbonate ~10 days. Pinning frequency by ester.

Cycle & Stacking Guide

Cutting and recomp. Pair with a testosterone base at 1:1 or 1.5:1 ratio. Not for first or second cycles.

Manufacturer Notes

Astera Labs produces a broad catalogue from research peptides to AAS oils. Lyophilised peptide vials ship with stability documentation.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Trenbolone Hexahydrobenzylcarbonate 100 mg Astera Labs”

Your email address will not be published. Required fields are marked *

Trenbolone Acetate

Physical & Chemical Properties for Research Purposes
Chemical structure of Trenbolone Acetate (C20H24O3) for laboratory analysis
2D structural representation · PubChem CID 24822 ↗
Chemical Identity
# CAS Registry Number 10161-34-9
Σ IUPAC Name [(8S,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,14-hexahydro-1H-cyclopenta[a]phenanthrene-17-yl] acetate
F Molecular Formula C20H24O3
M Molecular Weight 312.41 g/mol
SMILES CC(=O)O[C@@H]1CC[C@@H]2C3=CC=C4CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C
InChIKey FNYKCQMZFXUVMA-LKBHZCJUSA-N
Melting Point 96-97 °C
Solubility Practically insoluble in water; soluble in oils and organic solvents
Biological Half-life 1 day (IM)
PubChem CID 24822 ↗
Pharmacological Profile
Anabolic Rating 500
Androgenic Rating 500
Aromatization None
Hepatotoxicity Low
Detection Time 5 months

Clinical Notes

19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.

Known trade names: Finajet, Finaplix, Trenbol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.